Document is current
Any future updates will be listed below
-
Authors
Gingele, Arno Joachim https://orcid.org/0000-0002-4184-9866
Amin, Hesam
Vaassen, Aniek
Schnur, Ivana
Pearl, Cathy
Brunner-La Rocca, Hans-Peter
Boyne, Josiane
-
Funding
Funding for this research was provided by:
Novartis Pharma
Interreg North-West Europe (NWE 702)
- License Information
-
More Information
Article History
Received: 2 September 2022
Accepted: 29 December 2022
First Online: 2 February 2023
Conflict of interest
: J. Boyne and H.-P. Brunner-La Rocca received an unrestricted grant from Novartis Pharma B.V.; I. Schnur is co-founder and Chief Medical Officer of Sensely; C. Pearl was employee at Sensely; A. Vaassen is employee at Sananet Care. A.J. Gingele and H. Amin declare that they have no competing interests.
